Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584844 · ClinicalTrials.gov registry record · Phase 2
Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
A Phase 2 study, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- Phase 2
- Development phase
- 484
- Enrollment target
NCT00584844: Completed Phase 2 study, sponsored by U.S. Army Medical Research and Development Command.
NCT00584844 is a Phase 2 study that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 484 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (264% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00584844, a Phase 2 study, has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 484 participants
- Enrollment target
Study Summary
This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine
Primary Outcome
AE analysis was conducted for all intent-to-treat subjects regardless of compliance with titer schedule.
Interventions
- BIOLOGICAL Live F tularensis Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 484 participants |
| Start Date | 2004-10 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
What the finished NCT00584844 record still lists
NCT00584844 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (264% higher).
The record links to 0 conditions, and to 1 intervention - of which Live F tularensis Vaccine is the first listed.
NCT00584844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00584844 about?
NCT00584844 is a clinical study titled "Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine". This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine
What is the current status of trial NCT00584844?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 484 participants. The study started on 2004-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00584844?
The interventions under investigation include: Live F tularensis Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00584844?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00584844's enrollment target sits among peer trials
484 76th of 2000 higher than 1,925 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia